Insider Transactions in Q3 2024 at Cme Group Inc. (CME)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
12
+0.51%
|
$2,616
$218.5 P/Share
|
|
Sep 25
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
280
+0.11%
|
$61,040
$218.5 P/Share
|
|
Sep 16
2024
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,456
+22.44%
|
$5,985,408
$218.53 P/Share
|
|
Sep 16
2024
|
Julie Holzrichter Sr MD Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+8.18%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+23.41%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+9.72%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
852
+3.49%
|
$185,736
$218.53 P/Share
|
|
Sep 16
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+26.31%
|
$673,184
$218.53 P/Share
|
|
Sep 16
2024
|
Michael G. Dennis Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct |
2,744
+30.28%
|
$598,192
$218.53 P/Share
|
|
Sep 16
2024
|
Jonathan L Marcus Sr MD General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,744
+27.14%
|
$598,192
$218.53 P/Share
|
|
Sep 16
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+9.05%
|
$673,184
$218.53 P/Share
|
|
Sep 16
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+17.61%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+10.25%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+12.42%
|
$673,184
$218.53 P/Share
|
|
Sep 16
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+24.46%
|
$673,184
$218.53 P/Share
|
|
Sep 15
2024
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,583
-4.12%
|
$341,928
$216.99 P/Share
|
|
Sep 15
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-15.54%
|
$325,296
$216.99 P/Share
|
|
Sep 15
2024
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,467
-4.68%
|
$316,872
$216.99 P/Share
|
|
Sep 15
2024
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-1.1%
|
$54,432
$216.99 P/Share
|
|
Sep 15
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
886
-13.74%
|
$191,376
$216.99 P/Share
|
|
Sep 15
2024
|
Jonathan L Marcus Sr MD General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-5.54%
|
$58,536
$216.99 P/Share
|
|
Sep 15
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,314
-4.49%
|
$283,824
$216.99 P/Share
|
|
Sep 15
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
754
-5.38%
|
$162,864
$216.99 P/Share
|
|
Sep 15
2024
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,546
-5.24%
|
$333,936
$216.99 P/Share
|
|
Sep 15
2024
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,292
-6.46%
|
$279,072
$216.99 P/Share
|
|
Sep 15
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
755
-10.48%
|
$163,080
$216.99 P/Share
|
|
Sep 03
2024
|
Bryan T Durkin Director |
SELL
Bona fide gift
|
Direct |
465
-0.84%
|
-
|
|
Aug 30
2024
|
Bryan T Durkin Director |
SELL
Open market or private sale
|
Direct |
7,593
-12.01%
|
$1,624,902
$214.59 P/Share
|